# Ruth García‐Romero

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ruth-garcia-romero/

## Facts

| Field | Value |
| --- | --- |
| Citations | 736 |
| Field | Inflammatory Bowel Disease |
| h-index | 13 |
| i10-index | 17 |
| Last Known Institution | Hospital Universitario Miguel Servet |
| OpenAlex ID | https://openalex.org/A5022004258 |
| ORCID iD | 0000-0002-3017-1340 |
| Works | 76 |

## Researcher papers

- [Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study](https://scholariq.org/papers/step-up-empiric-elimination-diet-for-pediatric-and-adult-eosinophilic-2/)
- [Step-Up Empiric Elimination Diet for Pediatric and Adult Eosinophilic Esophagitis: The 2-4-6 Study](https://scholariq.org/papers/step-up-empiric-elimination-diet-for-pediatric-and-adult-eosinophilic/)
- [Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP](https://scholariq.org/papers/predictors-of-response-to-exclusive-enteral-nutrition-in-newly-diagnosed-crohn-s/)
- [Analysis of the Spanish national registry for pediatric home enteral nutrition (NEPAD): implementation rates and observed trends during the past 8 years](https://scholariq.org/papers/analysis-of-the-spanish-national-registry-for-pediatric-home-enteral-nutrition/)
- [Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis](https://scholariq.org/papers/proton-pump-inhibitor-therapy-in-pediatric-eosinophilic-esophagitis/)
- [Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease](https://scholariq.org/papers/gene-signatures-of-early-response-to-anti-tnf-drugs-in-pediatric-inflammatory/)
- [Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease](https://scholariq.org/papers/whole-transcription-profile-of-responders-to-anti-tnf-drugs-in-pediatric/)
- [Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study](https://scholariq.org/papers/safety-and-effectiveness-of-vedolizumab-in-paediatric-patients-with-inflammatory/)
- [Genetic Predictors of Long‐term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease](https://scholariq.org/papers/genetic-predictors-of-long-term-response-to-antitumor-necrosis-factor-agents-in/)
- [Pharmacogenetics of trough serum anti‐TNF levels in paediatric inflammatory bowel disease](https://scholariq.org/papers/pharmacogenetics-of-trough-serum-anti-tnf-levels-in-paediatric-inflammatory/)
- [Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study](https://scholariq.org/papers/early-use-of-teduglutide-in-paediatric-patients-with-intestinal-failure-is/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Child Nutrition and Feeding Issues](https://scholariq.org/topics/child-nutrition-and-feeding-issues/)

## Researcher university

- [Hospital Universitario Miguel Servet](https://scholariq.org/institutions/hospital-universitario-miguel-servet/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.